吸入一酸化窒素市場：用途別、エンドユーザー別-2025-2030年の世界予測

吸入一酸化窒素市場は、2023年に7億7,821万米ドルと評価され、2024年には8億2,109万米ドルに達すると予測され、CAGR 5.83%で成長し、2030年には11億5,738万米ドルに達すると予測されています。

吸入一酸化窒素（iNO）は、主に新生児および成人患者における呼吸不全と肺高血圧症の治療に使用される重要な治療薬です。iNO市場の範囲は、病院や専門クリニックを含むヘルスケア環境における様々な用途を包含しています。iNOは、新生児や特定の心臓手術における肺血管拡張の管理に広く使用され、最終用途の範囲を拡大しています。市場成長は、患者の転帰とコンプライアンスを改善する携帯型デバイスなどの送達システムにおける技術進歩の影響を強く受けています。非侵襲的かつ低侵襲的な治療オプションに対する需要の高まりは、市場の潜在力をさらに強化しています。最新のビジネスチャンスは新興市場や未開拓の人口動態にあり、戦略的な拡大や研究開発への投資が、新規の治療適応症や製剤を探索するために必要となります。さらに、ヘルスケア機関との提携は、普及と技術革新の一助となります。しかし、iNO療法の開発・提供に関連する厳しい規制要件や高コストが市場成長の課題となっています。さらに、代替治療やジェネリック製品との競合が進歩の妨げになることもあります。こうした制約があるにもかかわらず、iNOにおける技術革新の道筋には、送達メカニズムの改善、効率の向上、治療適応の拡大などがあります。相乗効果を狙ってiNOを他の治療薬と併用する調査も、もう一つの成長ベクトルを提供します。市場の特徴は、高い競争と急速な技術革新です。成功を目指す企業は、iNO治療の有効性と安全性を高め、規制当局の承認を合理化し、地理的・人口統計学的リーチを拡大することに注力すべきです。これらの側面に取り組むことで、企業は成長する市場情勢において効果的にシェアを獲得し、拡大することができます。

市場力学：急速に進化する吸入一酸化窒素市場の主要市場インサイトを公開

吸入一酸化窒素市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の呼吸器疾患の増加
  • ヘルスケア支出の増加に伴う新生児集中治療施設の増加
• 市場抑制要因
  • 吸入一酸化窒素を含む治療に伴う高コスト
• 市場機会
  • 吸入一酸化窒素の生産・貯蔵技術の向上
  • 吸入一酸化窒素の応用を促進するための継続的研究
• 市場の課題
  • 吸入一酸化窒素使用に対する政府の厳しい規制

ポーターの5つの力：吸入一酸化窒素市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、吸入一酸化窒素市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：吸入一酸化窒素市場における外部からの影響の把握

外部マクロ環境要因は、吸入一酸化窒素市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析吸入一酸化窒素市場における競合情勢の把握

吸入一酸化窒素市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス吸入一酸化窒素市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、吸入一酸化窒素市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で呼吸器疾患の発生が増加
    • ヘルスケア費の増加に伴う新生児集中治療施設の増加
  • 抑制要因
    • 吸入一酸化窒素に関連する治療には高額な費用がかかる
  • 機会
    • 吸入一酸化窒素の生産・保管技術の向上
    • 吸入一酸化窒素の応用を促進するための継続的な調査
  • 課題
    • 吸入一酸化窒素の使用に関する厳格な政府規制
• 市場セグメンテーション分析
  • 応用：慢性閉塞性肺疾患の発生率の増加
  • エンドユーザー：新生児および集中治療室向けの病院における吸入一酸化窒素デバイスの導入が増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 吸入一酸化窒素市場：用途別

• 急性呼吸促拍症候群
• 慢性閉塞性肺疾患
• マラリア治療
• 新生児呼吸器治療
• 結核治療

第7章 吸入一酸化窒素市場：エンドユーザー別

• クリニック
• 病院

第8章 南北アメリカの吸入一酸化窒素市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の吸入一酸化窒素市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの吸入一酸化窒素市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • Vero Biotech、一酸化窒素送達システム向けに6,500万米ドルの信用枠を確保
  • サードポール、一酸化窒素送達システムの試験で最初の患者に投与
  • マリンクロット社、INOmax EVOLVE DSデリバリーシステムのFDA認可とINOmax（一酸化窒素）ミニシリンダーの承認を発表
  • UABの研究者が肺高血圧症患者の生活の質を改善できるデバイスの開発に助成金を受領
  • ビヨンドエア、最大4,000万米ドルの借入資金を確保
  • VERO Biotech、革新的なタンクレス配送システムの商業化を加速するために3,000万米ドルを調達
  • VERO Biotechが第3世代のタンクレス吸入一酸化窒素デリバリーシステムのFDA承認を取得
  • SaNOtize、 COVID-19の治療と予防のための鼻スプレーを含む一酸化窒素ベースの治療薬の開発を進めるため、シリーズB資金調達で2,400万米ドルを調達すると発表

企業一覧

• Air Liquide SA
• Beyond Air, Inc.
• GE HealthCare Technologies, Inc.
• Getinge AB
• Linde PLC
• Mallinckrodt PLC
• Matheson Tri-Gas, Inc. by Mitsubishi Chemical Group Corporation
• Merck KGaA
• NIOX Group PLC
• Perma Pure LLC by Halma PLC
• SOL Group
• Third Pole, Inc.
• VERO Biotech Inc.

LIST OF FIGURES

• FIGURE 1. INHALED NITRIC OXIDE MARKET RESEARCH PROCESS
• FIGURE 2. INHALED NITRIC OXIDE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. INHALED NITRIC OXIDE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. INHALED NITRIC OXIDE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. INHALED NITRIC OXIDE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. INHALED NITRIC OXIDE MARKET DYNAMICS
• TABLE 7. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY MALARIA TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL RESPIRATORY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY TUBERCULOSIS TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 23. CANADA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. CANADA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 35. CHINA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. CHINA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 37. INDIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. INDIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 72. ITALY INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. ITALY INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 80. POLAND INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. POLAND INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 82. QATAR INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. QATAR INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 102. INHALED NITRIC OXIDE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 103. INHALED NITRIC OXIDE MARKET, FPNV POSITIONING MATRIX, 2023

The Inhaled Nitric Oxide Market was valued at USD 778.21 million in 2023, expected to reach USD 821.09 million in 2024, and is projected to grow at a CAGR of 5.83%, to USD 1,157.38 million by 2030.

Inhaled Nitric Oxide (iNO) serves as a critical therapeutic agent primarily used for the treatment of respiratory failure and pulmonary hypertension in neonatal and adult patients. The scope of the iNO market encompasses a range of applications in healthcare settings, including hospitals and specialized clinics. The increasing incidence of chronic respiratory diseases and a growing preterm birth rate significantly drive the necessity for this therapeutic gas. iNO is extensively used to manage pulmonary vasodilation in neonates and certain cardiac surgeries, expanding its end-use scope. Market growth is strongly influenced by technological advancements in delivery systems, such as portable devices, which improve patient outcomes and compliance. The rising demand for non-invasive and minimally invasive therapeutic options further reinforces its market potential. Latest opportunities lie in emerging markets and untapped demographics, necessitating strategic expansion and investment in R&D to explore novel therapeutic indications and formulations. Additionally, partnerships with healthcare institutions can aid in widespread adoption and innovation. However, market growth faces challenges from stringent regulatory requirements and high costs associated with the development and delivery of iNO therapies. Furthermore, competition from alternative treatments and generic products can hinder advancements. Despite such limitations, innovation avenues in iNO include improving delivery mechanisms, increasing its efficiency, and expanding its therapeutic indications. Research into combining iNO with other therapeutic agents for synergistic effects offers another growth vector. The market is characterized by a blend of high competition and rapid innovation. Companies aiming for success should focus on enhancing the efficacy and safety of iNO treatments, streamline regulatory approvals, and expand their geographic and demographic reach. By addressing these aspects, businesses can effectively capture and expand their share in the growing inhaled nitric oxide market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Inhaled Nitric Oxide Market

The Inhaled Nitric Oxide Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidents of respiratory disorders worldwide
  • Increase in neonatal intensive care facilities with growing healthcare expenditure
• Market Restraints
  • High cost associated with treatments involving inhaled nitric oxide
• Market Opportunities
  • Improvements in production and storage technologies of inhaled nitric oxide
  • Continuous research to boost the application of inhaled nitric oxide
• Market Challenges
  • Stringent government regulations for inhaled nitric oxide usage

Porter's Five Forces: A Strategic Tool for Navigating the Inhaled Nitric Oxide Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Inhaled Nitric Oxide Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Inhaled Nitric Oxide Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Inhaled Nitric Oxide Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Inhaled Nitric Oxide Market

A detailed market share analysis in the Inhaled Nitric Oxide Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Inhaled Nitric Oxide Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Inhaled Nitric Oxide Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Inhaled Nitric Oxide Market, highlighting leading vendors and their innovative profiles. These include Air Liquide SA, Beyond Air, Inc., GE HealthCare Technologies, Inc., Getinge AB, Linde PLC, Mallinckrodt PLC, Matheson Tri-Gas, Inc. by Mitsubishi Chemical Group Corporation, Merck KGaA, NIOX Group PLC, Perma Pure LLC by Halma PLC, SOL Group, Third Pole, Inc., and VERO Biotech Inc..

Market Segmentation & Coverage

This research report categorizes the Inhaled Nitric Oxide Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Application, market is studied across Acute Respiratory Distress Syndrome, Chronic Obstructive Pulmonary Disease, Malaria Treatment, Neonatal Respiratory Treatment, and Tuberculosis Treatment.
• Based on End-Users, market is studied across Clinic and Hospital.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidents of respiratory disorders worldwide
    • 5.1.1.2. Increase in neonatal intensive care facilities with growing healthcare expenditure
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with treatments involving inhaled nitric oxide
  • 5.1.3. Opportunities
    • 5.1.3.1. Improvements in production and storage technologies of inhaled nitric oxide
    • 5.1.3.2. Continuous research to boost the application of inhaled nitric oxide
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent government regulations for inhaled nitric oxide usage
• 5.2. Market Segmentation Analysis
  • 5.2.1. Application: Increasing incidences of chronic obstructive pulmonary disease
  • 5.2.2. End-Users: Growing deployment of inhaled nitric oxide devices in hospitals for neonatal and intensive care units
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Inhaled Nitric Oxide Market, by Application

• 6.1. Introduction
• 6.2. Acute Respiratory Distress Syndrome
• 6.3. Chronic Obstructive Pulmonary Disease
• 6.4. Malaria Treatment
• 6.5. Neonatal Respiratory Treatment
• 6.6. Tuberculosis Treatment

7. Inhaled Nitric Oxide Market, by End-Users

• 7.1. Introduction
• 7.2. Clinic
• 7.3. Hospital

8. Americas Inhaled Nitric Oxide Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Inhaled Nitric Oxide Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Inhaled Nitric Oxide Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. Vero Biotech Secures USD 65 Million Credit Facility for Nitric Oxide Delivery System
  • 11.3.2. Third Pole Doses First Patient in Trial with Nitric Oxide Delivery System
  • 11.3.3. Mallinckrodt Announces FDA Clearance of the INOmax EVOLVE DS Delivery System and Approval of the INOmax (Nitric Oxide) Mini-Cylinder
  • 11.3.4. UAB Researchers Receive Grant to Develop Devices That Can Improve Quality of Life for Patients with Pulmonary Hypertension
  • 11.3.5. Beyond Air Secures up to USD 40 Million Debt Financing
  • 11.3.6. VERO Biotech Raises USD 30 Million to Accelerate Commercialization of Its Innovative Tankless Inhaled Nitric Oxide Delivery System
  • 11.3.7. VERO Biotech Receives FDA Approval of its Third Generation Tankless Inhaled Nitric Oxide Delivery System
  • 11.3.8. SaNOtize Announces USD 24 Million in Series B Funding to Advance It's Nitric Oxide-Based Therapeutics, Including Nasal Spray for the Treatment and Prevention of COVID-19

Companies Mentioned

• 1. Air Liquide SA
• 2. Beyond Air, Inc.
• 3. GE HealthCare Technologies, Inc.
• 4. Getinge AB
• 5. Linde PLC
• 6. Mallinckrodt PLC
• 7. Matheson Tri-Gas, Inc. by Mitsubishi Chemical Group Corporation
• 8. Merck KGaA
• 9. NIOX Group PLC
• 10. Perma Pure LLC by Halma PLC
• 11. SOL Group
• 12. Third Pole, Inc.
• 13. VERO Biotech Inc.